Skip to main content
letter
. 2014 Feb 14;63(8):1367–1368. doi: 10.1136/gutjnl-2013-306555

Table 1.

The table illustrates MVK gene mutations with RefSeq mRNA (NM_000431.2)

Gene dbSNP Change Ref Obs P1 P2 P3 P4 P5 P6
MVK
NM_000431.2 (Chr 12)
rs104895334 c.16_34del; p.Leu6_Gly12delinsGlyfs CCTACTGGTGTCTGCTCCGG C WT WT WT HET WT WT
rs104895336 c.G394A; p.V132I G A HET WT WT WT WT WT
rs104895297 c.C404T; p.S135L C T WT WT HET WT WT WT
rs104895304 c.T803C; p.I268T T C WT WT WT WT HET WT
rs104895358 c.G1006A; p.G336S G A WT WT WT WT WT HOM
rs28934897 c.G1129A; p.V377I G A HOM HOM HET HET HET WT

For each mutation, the following are shown: the respective identifier (dbSNP), the nucleotide substitution and, if present, the amino acid change (Change), the reference sequence (Ref) and the one observed (Obs). For each of the six patients (P1, P2, P3, P3, P4, P5, P6), the mutation is identified as wild-type (WT), heterozygous (HET) or homozygous (HOM).

MVK, mevalonate kinase.